Why Can't We Find an Antidepressant That Really Works?
Turn any article into a podcast. Upgrade now (https://thedispatch.com/join/) to start listening.
Premium Members (https://thedispatch.com/join/) can share articles with friends & family to bypass the paywall.
The Search for Effective Antidepressants: A Complex Journey
The quest for finding an antidepressant that truly works is a complex and ongoing journey. While some individuals, like Catherine Livingston, have found relief with medications like Lexapro, others, such as Stephanie Lowry Smith, have endured a long and frustrating process of trial and error with various drugs.
The origins of modern antidepressant medication can be traced back to the 1950s when researchers discovered the potential of tuberculosis drugs like iproniazid in treating mood disorders. However, these early findings came with caveats, including side effects and limited effectiveness for specific populations.
The idea of serotonin, a neurotransmitter and hormone, as a key player in mood disorders emerged, leading to the monoamine deficiency hypothesis. This hypothesis has guided the development of selective serotonin reuptake inhibitors (SSRIs), which are now the most commonly prescribed antidepressants. However, the effectiveness of SSRIs varies widely among individuals, leaving many questions unanswered.
One major trial found that only about 30% of patients treated with the SSRI citalopram reached remission, and switching to other medications only slightly increased overall remission rates. This highlights the challenge of finding an antidepressant that works for everyone.
The complexity of depression as a disorder is further compounded by the fact that it likely has both genetic and environmental components. Simply put, there is no depression gene, and symptoms can vary widely among individuals. This makes diagnosing and treating depression a complex and individualized process.
Researchers are exploring new avenues, such as ketamine, which has shown promise in treating treatment-resistant depression. However, it's important to note that ketamine can cause dissociation and hallucinations, and its use should be in a controlled clinical setting.
In the pursuit of more effective antidepressants, researchers are also developing blood tests to measure cellular-level reactions typical in depressed people. Additionally, precision psychiatry aims to tailor medicine to the individual, potentially avoiding the trial-and-error approach that many face.
Despite the challenges, there is hope for the future of antidepressant treatment. With technological advancements and expanding treatment options, researchers are optimistic about finding better ways to approach and prevent depression, ultimately reducing suffering and burden for those affected.
